GoodRx Holdings (GDRX) Revenue (2019 - 2026)

GoodRx Holdings' Revenue history runs 8 years deep, the most recent figure standing at $194.0 million for Q1 2026.

• In Q1 2026, Revenue fell 4.42% year-over-year to $194.0 million; the TTM figure through Mar 2026 stood at $787.9 million (down 1.19% YoY), while the FY2025 annual figure was $796.9 million, up 0.57% from the prior year.
• Revenue came in at $194.0 million for Q1 2026 at GoodRx Holdings, roughly flat from $194.8 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $203.3 million in Q1 2022 to a low of $180.0 million in Q3 2023.
• A 5-year average of $194.1 million and a median of $195.3 million in 2024 frame the typical range for Revenue.
• On a YoY basis, Revenue climbed as much as 26.74% in 2022 and fell as far as 13.67% in 2022.
• GoodRx Holdings' Revenue stood at $184.1 million in 2022, then climbed by 6.81% to $196.6 million in 2023, then advanced by 0.99% to $198.6 million in 2024, then fell by 1.91% to $194.8 million in 2025, then declined by 0.4% to $194.0 million in 2026.
• According to Business Quant data, Revenue over the past three periods registered $194.0 million, $194.8 million, and $196.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison